Between 2010 and 2012 , 20 U.S. institutions participated in a prospective , Food and Drug Administration-approved randomized trial to evaluate percutaneous femoral artery access and closure by a `` preclose '' technique in conjunction with endovascular abdominal aortic aneurysm repair .